tetrathiomolybdate

Tetrathiomolybdate (TM) is used in the clinic for the treatment of Wilson’s disease by inducing dimerization of the metal-binding domain of the cellular copper efflux protein ATP7B (WLN4) through a unique sulfur-bridged Mo2S6O2 cluster.
Supplier Selleck Chemicals
Product # E1166
Sku # E1166-5mg
Pricing 5mg, $290.00
Feedback